Search

Help shape the future of mild to moderate hearing loss research

A James Lind Alliance Priority Setting Partnership has been formed to help shape the future of research into mild-moderate hearing loss. Who is the Priority Setting Partnership? The Partnership brings together Hearing Link, Action on Hearing Loss, the British Society...

Hearing loss and Alport syndrome

Alport syndrome (AS) includes a group of hereditary diseases caused by mutations in the COL4A3, COL4A4 or COL4A5 genes. These genes are responsible for the biosynthesis of α3, α4 and α5 collagen IV chains, which are located in the glomerular...

Clinical WG1. Establishing a standard for tinnitus: patient assessment and characterisation

Rilana Cima and Haúla Haider introduce an ambitious pan-European collaboration that seeks to establish guidelines for achieving best clinical practice for managing, assessing and treating patients with different tinnitus profiles. Tinnitus heterogeneity is the major reason for inconsistent results in...

Innovating around access to hearing services during the pandemic

COVID-19 has also presented its challenges to hearing healthcare providers and to the industry and, similarly, called for innovation and creativity. Dr Bromwich describes how these sectors are rising to the challenge. The reality of COVID-19 has been a challenging...

My experience of implementing remote care during COVID-19

When the COVID-19 pandemic hit, it is safe to say very few audiology services were fully prepared for the challenges it would pose. Gina Angley, Associate Director Adult Amplification Program, Vanderbilt University, tells us about her experience of preparing her...

Addressing the hearing needs of people with dementia

Dr Dawes provides a comprehensive overview of hearing needs of persons with dementia coupled with recommended guidelines for hearing-related considerations when assessing and intervening with persons with dementia. With ageing populations, we face a global dementia challenge. Rates of both...

Kuduwave™ testing aboard the ISS

What does it take to make an audiometer and tympanometry ready for the space age? In a recent interview, Jillian Scotland and Dirk Koekemoer shared their first-hand experience of getting the Kuduwave ready for a voyage to the ISS. It...

The lessons in setting up a community ENT service in the NHS

Sudeb Mandal, a GP with special interest in ENT, talks about the novel approach taken in the community to deliver ENT services in Kent in the UK. The Kent Community ENT service was born with the vision to bring together...

Listening differences in autistic individuals

In this article Erin Schafer, Lauren Mathews and Andrea Dunn outline the common auditory issues that autistic individuals face in comparison with their neurotypical peers and highlight the need to move beyond the traditional audiologic test battery when working with...

COOL therapy for cisplatin-induced hearing loss

Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...

Innovations in remote/teleaudiology patient care

Audiometry remains the gold standard in hearing evaluations. Changes in the delivery of audiometry remain a key challenge in providing a telehealth approach to hearing care. The team at Lyon University Hospital validated an innovative approach to solving this challenge,...

Platinum-based chemotherapy, tinnitus and hearing loss

Fortunately, the five-year survival rate of adult cancers is increasing. However, we are seeing for the first time the lasting effects of cancer treatments on people. As more people live with the long-term effects of treatment, such as chemotherapy, it is imperative to understand the impact it has on quality of life.